The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients
Open Access
- 2 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 154 (1) , 35-40
Abstract
Introduction: Vestibular schwannoma (VS) is a benign intracranial tumor in which the underlying genetics is largely uncertain, apart from mutations in the tumor suppressor gene NF2. Alternative tumorigenic mechanisms have been proposed, including a recurrent in-frame fusion transcript of the HTRA1 and SH3PXD2A genes. The gene product of the SH3PXD2A-HTRA1 fusion has been shown to promote proliferation, invasion and resistance to cell death in vitro and tumor growth in vivo. The aim of this study was to replicate the findings and to investigate the frequency of this fusion gene in another cohort of vestibular schwannoma patients. Methods: The SH3PXD2A-HTRA1 transcript was synthesized in vitro using PCR and used as a positive control to assess the sensitivity of a real-time PCR assay. This real-time PCR assay was used to search for the presence of the fusion transcript in 121 Norwegian sporadic VS patients. Results: The real-time PCR assay showed a high sensitivity and was able to detect as low as ~ 5 copies of the fusion transcript. Out of the 121 investigated tumors, only 1 harbored the SH3PXD2A-HTRA1 fusion. Conclusion: Even though the SH3PXD2A-HTRA1 fusion has been shown to be a driver of tumorigenesis, our results suggest that it is a rare event in our VS patients. Further investigation is warranted in order to elucidate whether our results represent an extreme, and if the fusion is present also in other neoplasms.Keywords
Funding Information
- University of Bergen
This publication has 14 references indexed in Scilit:
- Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesisOncogene, 2018
- Genetic landscape of sporadic vestibular schwannomaJournal of Neurosurgery, 2018
- Editorial. Refining manuscript elements in the Journal of Neurosurgery: when less is moreJournal of Neurosurgery, 2018
- The genomic landscape of schwannomaNature Genetics, 2016
- The Changing Landscape of Vestibular Schwannoma Management in the United States—A Shift Toward ConservatismOtolaryngology–Head and Neck Surgery, 2015
- Socio-demographic distribution of vestibular schwannomas in DenmarkActa Oto-Laryngologica, 2014
- Conservative Management or Gamma Knife Radiosurgery for Vestibular SchwannomaNeurosurgery, 2013
- Integrative genomics viewerNature Biotechnology, 2011
- Global Gene Expression Profiling and Tissue Microarray Reveal Novel Candidate Genes and Down-Regulation of the Tumor Suppressor Gene CAV1 in Sporadic Vestibular SchwannomasNeurosurgery, 2010
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007